| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
| 07/06/2005 | CN1636050A Core-glycosylated HCV envelope proteins |
| 07/06/2005 | CN1636018A 组织特异性表达 Tissue-specific expression |
| 07/06/2005 | CN1636013A DNA vaccines encoding HIV accessory proteins |
| 07/06/2005 | CN1635905A Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 07/06/2005 | CN1209460C No.6 gene segment of rice dwarfing virus |
| 07/05/2005 | US6913927 Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| 07/05/2005 | US6913923 Virus envelope vector for gene transfer |
| 07/05/2005 | US6913922 Serotype of adenovirus and uses thereof |
| 07/05/2005 | US6913753 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/05/2005 | US6913752 Characterized by the loss of its capability to reproductively replicate in human cell lines. |
| 07/05/2005 | US6913751 Recombinant avian herpesvirus useful in vaccine production |
| 06/30/2005 | WO2005059161A2 Methods for evaluation a bacteriophage preparation |
| 06/30/2005 | WO2005059122A1 Pathogenic bovine enterovirus, vaccines, and diagnostic methods |
| 06/30/2005 | WO2005058357A1 Virus-like particle (vlp) as vaccine |
| 06/30/2005 | WO2005058356A2 Methods for porducing storage stable viruses and immunogenic compositions thereof |
| 06/30/2005 | WO2005058006A2 Methods and compositions comprising bacteriophage nanoparticles |
| 06/30/2005 | WO2005000881A3 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 06/30/2005 | WO2004063343A3 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 06/30/2005 | US20050142148 e.g. include antigenic gene product of another virus, such as influenza virus, respiratory syncytial virus, human metapneumovirus and avian pneumovirus; respiratory tract infections |
| 06/30/2005 | US20050142115 Papilloma pseudovirus and preparation |
| 06/30/2005 | US20050142111 Prevention of transplant arteriosclerosis and interstitial fibrosis by stable and long-term expression of heme oxygenase-1 in grafts |
| 06/30/2005 | US20050142064 Administering test drug infected with adenovirus used as a vector and engineered by incorporating a detectable reporter gene and having human PXR binding regions falling within an untranslated region of a human CY3A gene; genetic engineering and expression; gene therapy; drug screening |
| 06/30/2005 | CA2560045A1 Methods and compositions comprising bacteriophage nanoparticles |
| 06/30/2005 | CA2549197A1 Methods for producing storage stable viruses and immunogenic compositions thereof |
| 06/30/2005 | CA2547076A1 Pathogenic bovine enterovirus, vaccines, and diagnostic methods |
| 06/29/2005 | EP1546343A2 High titer recombinant aav production |
| 06/29/2005 | EP1546329A1 Gene expression system based on codon translation efficiency |
| 06/29/2005 | EP1546313A1 Thermostable rna ligase from thermus phage |
| 06/29/2005 | EP1546192A1 Orthopoxvirus vectors, genes and products thereof |
| 06/29/2005 | EP1545625A2 Flexible vaccine assembly and vaccine delivery platform |
| 06/29/2005 | EP1545594A1 Bacteriophage-mediated immunisation against hepatitis |
| 06/29/2005 | EP1309672B1 Method of producing infectious reovirus |
| 06/29/2005 | EP0864645B1 Negative-strand rna virus vector having autonomously replicating activity |
| 06/29/2005 | CN1633599A Methods of examining (-) strand RNA virus vectors having lowered ability to form grains and method of constructing the same |
| 06/29/2005 | CN1632109A Highly expressed recombinant gutted adenovirus containing human constant region whole antibody gene and its use |
| 06/29/2005 | CN1208463C Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4 |
| 06/29/2005 | CN1208340C An infections clone for human parainfluenza virus type 3 |
| 06/29/2005 | CN1208091C Virus deactivating method with immobilized solvent or immobilized solvent-detergent |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | US6911197 Water soluble and non-peptidic polymer backbone having terminal carbon, such as a poly(alkylene glycol), terminal carbon of polymer backbone being directly bonded to nitrogen atom of N-maleimidyl moiety without linking group therebetween |
| 06/28/2005 | CA2232604C Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 06/23/2005 | WO2005056807A2 Bovine adeno-associated viral (baav) vector and uses thereof |
| 06/23/2005 | WO2005056805A1 Viral particles containing an alpha virus derived vector and method for preparing said viral particle |
| 06/23/2005 | WO2005056781A1 Use of proteins and peptides coded by the genome of a novel strain of sars-associated coronavirus |
| 06/23/2005 | WO2005056584A2 Novel strain of sars-associated coronavirus and applications thereof |
| 06/23/2005 | WO2005056583A2 Plant virus |
| 06/23/2005 | WO2005055957A2 Influenza immunogen and vaccine |
| 06/23/2005 | WO2005024039B1 Improved method for generating influenza viruses and vaccines |
| 06/23/2005 | WO2005023849A3 Antigenic peptides of rabies virus and uses thereof |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136399 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 06/23/2005 | US20050136037 Bacteriophage for lysis of Methylobacterium and compositions and uses thereof |
| 06/23/2005 | CA2549104A1 Influenza immunogen and vaccine |
| 06/23/2005 | CA2547922A1 Viral particles containing an alphavirus-derived vector and method for preparing said viral particle |
| 06/22/2005 | EP1543837A1 Virus-like particle (VLP) as vaccine |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | EP1543169A2 Method for determining sensitivity to a bacteriophage |
| 06/22/2005 | EP1543167A2 Large circular sense molecule array |
| 06/22/2005 | EP1543160A1 Uncoupling of dna propagation and expression of protein for phage display |
| 06/22/2005 | EP1543128A2 Viral vectors containing recombination sites |
| 06/22/2005 | EP1543113A1 Chicken astrovirus type 2 |
| 06/22/2005 | EP1017797B1 Non-primate lentiviral vectors and packaging systems |
| 06/22/2005 | EP0758397B1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 06/22/2005 | CN1630662A Rabbit hemorrhagic disease vaccine and antigens |
| 06/22/2005 | CN1629296A Recombinant vaccine using flavivirus as vector |
| 06/22/2005 | CN1629288A Recombinant Baculovirus for expressing CTB and human insulin fusion protein and use thereof |
| 06/21/2005 | US6908618 Production of novel bovine respiratory syncytial viruses from cDNAs |
| 06/21/2005 | US6908613 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/21/2005 | CA2239070C Systems and methods for removing viral agents from blood |
| 06/21/2005 | CA2182303C Method of preparing a viral vector by homologous intermolecular recombination |
| 06/16/2005 | WO2005054450A1 Compositions comprising fetal liver cells and methods useful for hcv infection |
| 06/16/2005 | WO2005054275A2 Nanofiltration of factor vii solutions to remove virus |
| 06/16/2005 | WO2005053516A2 Replication competent hepatitis c virus and methods of use |
| 06/16/2005 | WO2005040333A3 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 06/16/2005 | WO2005023180A3 Method for detecting cancer cells and monitoring cancer therapy |
| 06/16/2005 | WO2005023010A3 Disinfection of foodstuffs |
| 06/16/2005 | WO2004094476A3 Compositions and methods relating to stop-1 |
| 06/16/2005 | WO2004040976A8 Cryogenically protected viral delivery systems and related manufacture and use |
| 06/16/2005 | US20050130919 Allow for inhibition of the expression of target alleles in a spatially and temporally regulatable manner; useful for investigating gene functions; genetic engineering |
| 06/16/2005 | US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 06/16/2005 | US20050130131 Contacting macrophages in vitro with composition comprising hepatitis c viral particles, culture cells, incubate with non-macrophage cells, culture, recover viral particles; viricides and rational drug design |
| 06/16/2005 | US20050130127 Coronavirus-like particles comprising functionally deleted genomes |
| 06/16/2005 | US20050130123 Methods of examining (-) strand rna virus vectors having lowered ability to form grains and method of constructing the same |
| 06/16/2005 | US20050129713 For use in vaccine |
| 06/16/2005 | CA2547787A1 Compositions comprising fetal liver cells and methods useful for hcv infection |
| 06/16/2005 | CA2545474A1 Nanofiltration of factor vii solutions to remove virus |
| 06/15/2005 | EP1541682A2 Generation and selection of recombinant varied binding proteins |
| 06/15/2005 | EP1539974A1 Orthopoxvirus vectors, genes and products thereof |
| 06/15/2005 | EP1539939A1 Method for the production of virus-analog particles for packing biologically active macromolecule by in vitro assembly of capsomers to which the macromolecules are bound |
| 06/15/2005 | EP1539938A1 Chimeric gb virus b (gbv-b) |
| 06/15/2005 | EP1539937A2 Methods for propagating adenovirus and virus produced thereby |
| 06/15/2005 | EP1539808A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/15/2005 | EP1539786A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 06/15/2005 | EP1145010B1 Purification process using magnetic particles |
| 06/15/2005 | EP1106692B1 Rna virus vector having contact infiltration capability |
| 06/15/2005 | EP1012338B1 A tumor suppressor designated ts10q23.3 |
| 06/15/2005 | EP0977587B1 Chimeric flavivirus vaccines |
| 06/15/2005 | CN1626652A Method for accelerating quick growth of animals and method for improving quality of meat |
| 06/15/2005 | CN1206361C Construction and application of serial universal adenovirus accompanying virus carriers |